Age, Biography and Wiki
David Lane (biologist) (David Philip Lane) was born on 1 July, 1952 in Wimbledon, London, England, is a British immunologist, molecular biologist and cancer researcher. Discover David Lane (biologist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 71 years old?
| Popular As |
David Philip Lane |
| Occupation |
N/A |
| Age |
71 years old |
| Zodiac Sign |
Cancer |
| Born |
1 July, 1952 |
| Birthday |
1 July |
| Birthplace |
Wimbledon, London, England |
| Nationality |
London, England
|
We recommend you to check the complete list of Famous People born on 1 July.
He is a member of famous Researcher with the age 71 years old group.
David Lane (biologist) Height, Weight & Measurements
At 71 years old, David Lane (biologist) height not available right now. We will update David Lane (biologist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
David Lane (biologist) Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is David Lane (biologist) worth at the age of 71 years old? David Lane (biologist)’s income source is mostly from being a successful Researcher. He is from London, England. We have estimated David Lane (biologist)'s net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Researcher |
David Lane (biologist) Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Sir David Philip Lane (born 1 July 1952) is a British immunologist, molecular biologist and cancer researcher.
He is currently working in the Department of Microbiology, Tumor and Cell Biology at the Karolinska Institute and is Chairman of Chugai Pharmabody.
He is best known for the discovery of p53, one of the most important tumour suppressor genes.
Lane completed his undergraduate and postgraduate degrees at University College, London where he studied auto-immunity under the supervision of Avrion Mitchison.
Lane carried out postdoctoral research first at the Imperial Cancer Research Fund (ICRF) in London with Lionel Crawford and then at the Cold Spring Harbor Laboratory in New York with Joseph Sambrook.
On returning to the UK, Lane set up his own laboratory with Cancer Research Campaign (CRC) funding at Imperial College, London, then moving to the ICRF laboratories at Clare Hall before moving in 1990 to the University of Dundee to help establish the CRC laboratories there.
He has played an active part in UK science, sitting at various times on the scientific committee of the CRC, the Cell Board of the MRC, and on the council of the ICRF.
He has won many international prizes for his work including the Joseph Steiner Prize, the Meyenburg Prize (1995), the Yvette Mayent Prize, the Paul Ehrlich Prize and the Cancer Research UK Lifetime Achievement Prize (2012).
He has been awarded honorary degrees from the Universities of Toulouse, Birmingham, Aberdeen, Stirling, Abertay, Brno and Nottingham.
He has also been recognized for his business acumen with the award of Emerging Entrepreneur of the year.
Lane founded the Dundee-based Biotechnology company, Cyclacel Ltd and was the chief scientific officer from 1996 to 2004.
Lane is a member of the European Molecular Biology Organization (EMBO), and in 1996 was elected a Fellow of the Royal Society, the UK's premier Academy.
He is also a Fellow of the Royal Society of Edinburgh, the Royal College of Pathologists, the Royal College of Surgeons of Edinburgh and a founder member of the Academy of Medical Sciences.
He was knighted for his contribution to cancer research in the New Year honours list in January 2000.
From 2004 to 2007, he was the executive director of the Institute of Molecular & Cell Biology (IMCB) in Singapore.
Sir David was chief scientist of Singapore's Agency for Science, Technology and Research (A*STAR, Singapore).
He is also professor of tumour suppressor biology at the Department of Microbiology, Tumor and Cell Biology at the Karolinska Institute, where he is heading a research group.
Lane has published more than 350 research articles that have been cited over 100,000 times and is internationally recognised for his original discovery of the p53 protein SV40 T antigen complex and for his many subsequent contributions to the p53 field.
The p53 gene is the most frequently altered gene in human cancer with more than half of all cancers having mutant p53.
He is co-author with Ed Harlow of the most successful practical guide to the use of immunochemical methods.
The "Antibodies" manual has sold over 40,000 copies.
He is dedicated to the successful translation of research for patient benefit and participated in the early discussions around the scientific benefits of the merger of ICRF and CRC, before serving as chief scientist to their successor, Cancer Research UK, until 2010.
On 29 September 2016 The John Fisher School opened the Sir David Lane building.
